<DOC>
	<DOCNO>NCT00239460</DOCNO>
	<brief_summary>The objective study evaluate effect inhaled tiotropium bromide trough FEV1 assess cardiac effect 12-lead Holter ECG monitoring patient COPD .</brief_summary>
	<brief_title>Efficacy Safety ( Including 24-hour Holter Monitoring ) Tiotropium Inhalation Capsules Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>History COPD , FEV1 le equal 65 % , FEV1/FVC le equal 70 % Smoking history great equal 10 pack year Not history clinical diagnosis asthma and/or atopy A history thoracotomy pulmonary resection Patients require use supplemental oxygen therapy &gt; 12 hour per day Chronic use systemic corticosteroid unstable daily dose Patients recent history myocardial infarction A know hypersensitivity anticholinergic drug</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>